Stay updated on Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence” during a transition. It appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-25T16:08:59.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T22:00:05.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.7.1 instead of v3.7.0; the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T21:51:20.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the usual study record content, with the page header and footer still visible and a Home link present. This indicates access to the study view is blocked rather than updated study details being shown.
    Difference
    0.5%
    Check dated 2026-09-27T22:07:32.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page is displaying a 403 Forbidden error, replacing the study details and documents with a generic header and footer. This view prevents access to the study content and related documents.
    Difference
    17%
    Check dated 2026-09-20T20:40:58.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Israel study locations updated: Tel Litwinsky (52621) added and Qiryat Krinitzi (52621) removed. This changes the pool of active enrollment sites for the trial in Israel.
    Difference
    0.1%
    Check dated 2026-09-13T21:56:56.000Z thumbnail image

Stay in the know with updates to Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page.